Effect of tight control management on Crohn's disease (CALM): a multicentre, randomised, controlled phase 3 trial
Jean‐Frédéric Colombel(Icahn School of Medicine at Mount Sinai), Remo Panaccione(University of Calgary), Peter Bossuyt(Imelda Hospital), Milan Lukáš(Charles University), Filip Baert(AZ Delta), Tomáš Vaňásek, Ahmet Danalıoğlu(Bezmiâlem Vakıf Üniversitesi), Gottfried Novacek(Medical University of Vienna), Alessandro Armuzzi(Agostino Gemelli University Polyclinic), Xavier Hébuterne(Université Côte d'Azur), Simon Travis(Oxford University Hospitals NHS Trust), Silvio Danese(Humanitas University), Walter Reinisch(Medical University of Vienna), William J. Sandborn(University of California San Diego), Paul Rutgeerts(KU Leuven), Daniël W. Hommes(University of California, Los Angeles), Stefan Schreiber(University Hospital Schleswig-Holstein), Ezequiel Neimark(AbbVie (United States)), Bidan Huang(AbbVie (United States)), Qian Zhou(AbbVie (United States)), Paloma Méndez(Saint Louis University), Joel Petersson(AbbVie (United States)), Kori Wallace(AbbVie (United States)), Anne Robinson(AbbVie (United States)), Roopal Thakkar(AbbVie (United States)), Geert D’Haens(Amsterdam UMC Location University of Amsterdam)
Cited by 908
Abstract
Related Papers
No related papers found
Powered by citation graph analysis